Skip to main content
TipRanks
Go Ultimate75% OFF

Takeda Pharmaceutical Co (0RN3) Q2 2023 Earnings Report

4 Followers

GB:0RN3 Q2 2023 EPS Results

Actual EPS
-EUR 0.18
Consensus EPS
EUR 0.16
Beat/Miss
Missed by -EUR 0.34
One Year Ago EPS
EUR 0.23

GB:0RN3 Q2 2023 Revenue Results

Actual Revenue
EUR 5.97B
Expected Revenue
EUR 5.68B
Beat/Miss
Beat by +EUR 283.73M
YoY Revenue Growth
+4.07%

Earnings Announcement Details

Quarter
Q2 2023
Date
10/26/2023
Time
Before Open
Conference Call
Thursday, October 26, 2023
GB:0RN3 Upcoming Earnings

Takeda Pharmaceutical Co's next earnings date is estimated for January 28, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

GB:0RN3 Q2 2023 Earnings Call
0:00 / 0:00

Q2 2023 Earnings Slide Deck

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

GB:0RN3 Earnings History

GB:0RN3 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Jan 28, 20272026 (Q3)0.26-0.38――
Oct 29, 20262026 (Q2)0.260.69-0.041643.81% (+0.74)
Jul 30, 20262026 (Q1)0.310.410.45-9.76% (-0.04)
May 13, 20262025 (Q4)-0.14-0.09-0.3876.42% (+0.29)
Jan 28, 20262025 (Q3)0.250.380.09333.93% (+0.29)
Oct 30, 20252025 (Q2)0.12-0.040.33-113.45% (-0.38)
Jul 30, 20252025 (Q1)0.280.450.3530.16% (+0.11)
May 08, 20252024 (Q4)-0.05-0.38-0.01-3042.86% (-0.37)
Jan 30, 20252024 (Q3)0.150.090.39-77.59% (-0.30)
Oct 31, 20242024 (Q2)0.210.33-0.18287.77% (+0.51)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed